104 related articles for article (PubMed ID: 4720700)
1. Isoniazid inactivation in Finns and Lapps as demonstrated by various methods.
Tittinen H; Mattila MJ; Eriksson AW
Am Rev Respir Dis; 1973 Aug; 108(2):375-8. PubMed ID: 4720700
[No Abstract] [Full Text] [Related]
2. Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.
Tiitinen H
Scand J Respir Dis; 1969; 50(2):110-24. PubMed ID: 5195839
[No Abstract] [Full Text] [Related]
3. The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.
Mattila MJ; Tiitinen H
Ann Med Exp Biol Fenn; 1967; 45(4):423-7. PubMed ID: 5599058
[No Abstract] [Full Text] [Related]
4. Determination of the acetylator phenotype from the ratio of the urinary excretion of acetylisoniazid to acid-labile isoniazid: a study in Finnish Lapland.
Ellard GA; Gammon PT; Tiitinen H
Tubercle; 1973 Sep; 54(3):201-10. PubMed ID: 4773075
[No Abstract] [Full Text] [Related]
5. Comparison of the isoniazid inactivation in Finns and Lapps.
Tiitinen H; Mattila MJ; Eriksson AW
Ann Med Intern Fenn; 1968; 57(4):161-6. PubMed ID: 5731346
[No Abstract] [Full Text] [Related]
6. Distribution of isoniazid inactivators determined in Eskimos and Canadian college students by a urine test.
Eidus L; Hodgkin MM; Schaefer O; Jessamine AG
Rev Can Biol; 1974 Jun; 33(2):117-23. PubMed ID: 4851412
[No Abstract] [Full Text] [Related]
7. [Inactivation of isoniazid in children].
Paire M; Lavarenne J; Rodet MF
Therapie; 1984; 39(6):625-31. PubMed ID: 6531735
[No Abstract] [Full Text] [Related]
8. [Evaluation of the routine determination of the isoniazid acetylation phenotype using a microbiologic technic].
Benbachir M; El Mdaghri N; Bartal M; Bouayad EM; Benamour S; Bennani R
Maghrib Tibbi; 1983 Dec; 5(4):319-24. PubMed ID: 6676602
[No Abstract] [Full Text] [Related]
9. Simplified screening test for phenotyping of isoniazid inactivators.
Eidus L; Hodgkin MM
Int J Clin Pharmacol; 1973 Feb; 7(1):82-6. PubMed ID: 4699389
[No Abstract] [Full Text] [Related]
10. Isoniazid inactivation status and the development of chronic tuberculosis.
Tiitinen H
Scand J Respir Dis; 1969; 50(3):227-34. PubMed ID: 5195905
[No Abstract] [Full Text] [Related]
11. Inactivation of isoniazid by Canadian Eskimos and Indians.
Jeanes CW; Schaefer O; Eidus L
Can Med Assoc J; 1972 Feb; 106(4):331-5. PubMed ID: 5061127
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of isoniazid and sulphadimidine in mongoloid subjects.
Airaksinen E; Mattila MJ; Ollila O
Ann Med Exp Biol Fenn; 1969; 47(4):303-7. PubMed ID: 4246038
[No Abstract] [Full Text] [Related]
13. [HPLC study of blood isoniazid in patients with tuberculosis in Tunisia: significance and therapeutic results].
Barhoumi C; Masmoudi AS; Gritli N; Hamza M; Nsiri B; Amor A; Mechghoul S; Belhadj O
Tunis Med; 1995 Oct; 73(10):379-84. PubMed ID: 9506162
[No Abstract] [Full Text] [Related]
14. Bioavailability study with a new isoniazid preparation.
Eidus L; Hodgkin MM; Hsu AH
Int J Clin Pharmacol; 1973 Oct; 8(2):154-9. PubMed ID: 4762906
[No Abstract] [Full Text] [Related]
15. Use of sulphadimidine acetylation test in determining isoniazid inactivation rate in tuberculous patients.
Sen PK; Chatterjee R; Saha JR
Indian J Med Res; 1972 Jan; 60(1):28-39. PubMed ID: 5029122
[No Abstract] [Full Text] [Related]
16. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
Ellard GA; Ellard DR; Allen BW; Girling DJ; Nunn AJ; Teo SK; Tan TH; Ng HK; Chan SL
Am Rev Respir Dis; 1986 Jun; 133(6):1076-80. PubMed ID: 3717760
[TBL] [Abstract][Full Text] [Related]
17. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
Miscoria G; Leneveu A; Walle C; Roux A
Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
[TBL] [Abstract][Full Text] [Related]
18. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
Bouayad Z; Chevalier B; Maurin R; Bartal M
Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
[TBL] [Abstract][Full Text] [Related]
19. Isoniazid dosage in patients with renal failure.
Bowersox DW; Wintebauer RH; Stewart GL; Orme B; Barron E
N Engl J Med; 1973 Jul; 289(2):84-7. PubMed ID: 4710409
[No Abstract] [Full Text] [Related]
20. Determination of isoniazid and metabolites in biological fluids.
Boxenbaum HG; Riegelman S
J Pharm Sci; 1974 Aug; 63(8):1191-7. PubMed ID: 4851320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
